Filter
564
Filtered Results: 564
Text search:
United
Nations
Office4
on
Drugs
and
Crime
Featured
Recommendations
31
New Publications
129
Language
Document type
No document type
392
Studies & Reports
84
Guidelines
42
Strategic & Response Plan
16
Manuals
13
Fact sheets
5
Training Material
4
Situation Updates
4
Resource Platforms
2
Brochures
1
Infographics
1
Countries / Regions
Western and Central Europe
27
Ukraine
23
Global
18
Nigeria
14
Eastern Europe
14
India
13
Myanmar / Burma
12
Kenya
11
Uganda
10
Nepal
10
Russia
10
Syria
9
Zambia
8
South Africa
8
Latin America and the Carribbean
8
Asia
8
Congo, Democratic Republic of
7
Cambodia
7
Ghana
6
South Sudan
6
Mozambique
6
Colombia
6
South–East Asia Region
6
Africa
6
Namibia
5
Venezuela
5
Afghanistan
4
Thailand
4
Bangladesh
4
Central African Republic
4
North Macedonia
4
Senegal
3
Ethiopia
3
Philippines
3
Pakistan
3
Germany
3
Malawi
3
Lesotho
3
Yemen
3
Eastern Europe and Central Asia
3
Tajikistan
3
Sierra Leone
2
Liberia
2
Mali
2
Tanzania
2
Indonesia
2
Eswatini/ Swaziland
2
Brazil
2
Hungary
2
Mexico
2
West and Central Africa
2
Middle East and North Africa
2
Moldova
2
Kyrgyzstan
2
Georgia
2
Burkina Faso
1
Guinea-Bissau
1
Morocco
1
Zimbabwe
1
Haiti
1
Somalia
1
Jordan
1
Lebanon
1
Turkey
1
Rwanda
1
Ireland
1
Singapore
1
Sudan
1
Argentina
1
Serbia
1
Botswana
1
Libya
1
Angola
1
Sri Lanka
1
Chile
1
Bhutan
1
Poland
1
Palestine
1
Albania
1
Armenia
1
Southern Africa
1
Laos
1
Canada
1
Estonia
1
Uzbekistan
1
Kazakhstan
1
Vietnam
1
Turkmenistan
1
Jamaica
1
Mauritius
1
Norway
1
Portugal
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
151
Women & Child Health
24
Public Health
19
Clinical Guidelines
17
Key Resources
8
Capacity Building
3
Pharmacy & Technologies
1
Toolboxes
HIV
125
Mental Health
120
TB
44
COVID-19
25
Conflict
22
Refugee
21
Disability
13
Planetary Health
12
Global Health Education
9
Pharmacy
9
Rapid Response
6
Health Financing Toolbox
6
Ebola
3
AMR
3
Natural Hazards
2
Caregiver
2
NCDs
2
NTDs
1
Since the release of the first volume in May 2020, the COVID-19 pandemic has continued to rage around the world. By mid-March, 2021, countries around the globe had reported over 123 million cases—a nearly five-fold increase since this report’s previous volume—... over 2.7 million deaths attributed to the disease. And while new case loads are currently on the rise again, the global health community has already administered almost 400 million doses of vaccines, at last offering some signs of hope and progress.
Economic impacts threaten to undo decades of recent progress in poverty reduction, child nutrition and gender equality, and exacerbate efforts to support refugees, migrants, and other vulnerable communities. National and local governments—together with international and private-sector partners—must deploy vaccines as efficiently, safely and equitably as possible while still monitoring for new outbreaks and continuing policies to protect those who do not yet have immunity.
More than ever, the world needs reliable and trustworthy data and statistics to inform these important decisions. The United Nations and all member organizations of the Committee for the Coordination of Statistical Activities (CCSA) collect and make available a wealth of information for assessing the multifaceted impacts of the pandemic. This report updates some of the global and regional trends presented in Volume I and offers a snapshot of how COVID-19 continues to affect the world today across multiple domains.
These guidelines aim to guide all health care providers in Myanmar, accommodating the situation of different settings in the context of progressive decentralization of HIV services. Notable changes from the previous edition include:
• diagnosis of HIV
• update ... the initiation of ART
• new ARV drugs and regimens
• new recommendation on infant prophylaxis
• PrEP and PEP updates
• updates on co-infections and comorbidities management
It should be noted that these guidelines are meant for the operational level and are adapted and adopted in line with existing Myanmar context.
• diagnosis of HIV
• update ... the initiation of ART
• new ARV drugs and regimens
• new recommendation on infant prophylaxis
• PrEP and PEP updates
• updates on co-infections and comorbidities management
It should be noted that these guidelines are meant for the operational level and are adapted and adopted in line with existing Myanmar context.
The world is facing an unprecedented range of emergencies. In reaction to these complex adversities, many people experience considerable distress and impairment, and a minority may even go ... to develop mental health conditions. Meanwhile, those with pre-existing mental health conditions may experience a worsening of their condition and are at risk of neglect, abandonment, abuse and lack of access to support. Unfortunately, evidence-based mental health care is often extremely limited in humanitarian settings. In response, the World Health Organization (WHO) and the United Nations High Commissioner for Refugees (UNHCR) published the Mental Health Gap Action Programme (mhGAP) Humanitarian Intervention Guide (mhGAP-HIG) in 2015. This practical tool supports health-care providers in assessing and offering first-line management of mental, neurological and substance use (MNS) conditions in humanitarian emergency settings.
2 December 2021. The current report, Stories of change from four countries: Building capacity for integrating mental health care within health services across humanitarian settings, describes efforts in four countries to build evidence-based mental health systems in humanitarian emergency settings using the mhGAP-HIG. This report includes three sections, the first describing the importance of scaling up mental health care in emergency contexts, the second outlining case studies (“stories of change”) to scale up the Mental Health Gap Action Programme (mhGAP) programme in four settings and the third describing lessons learned by stakeholders.
Rapport mondial sur les drogues 2018
Consolidated guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection
recommended
2nd edition. These guidelines provide guidance on the diagnosis of human immunodeficiency virus (HIV) infection, the use of antiretroviral (ARV) drugs for treating ... preventing HIV infection and the care of people living with HIV. They are structured along the continuum of HIV testing, prevention, treatment and care
This Guidance was developed in response to the increase in HIV-related human rights crises and the shrinking civic space for rights-related responses to HIV in recent years across the world. This document builds upon existing guidance documents, off...
An Independent Report
of the West Africa Commission on Drugs
The "Questions and Answers on Prevention and control of Alcohol related harm" has been developed by WHO country ... in Viet Nam with technical contribution from national and international experts in the field. This publication provides scientific evidences on harms of alcohol use to the health of users as well as to others and society at large. It provides WHO recommendations for the most effective prevention measures in Viet Nam and will also help answer questions that policy makers may have on how to develop effective policies for prevention and control of alcohol related harms.
The United Nations Development Assistance Framework (UNDAF) 2018-2022 sets out the UN partnership aiming to support Nepal as it carves out its development agenda over the next five years. At the cor...
10 years after the UN general assembly special session on drugs
The occurrence of a high percentage of couterfeit medicines on the global medicines market is often attributed to a lack of effective regulation and a weak enforcement capacity. This review, while f...
EMCDDA Insights - 11
Accessed: 14.03.2019
